A 24-year-old woman with Rasmussen encephalitis diagnosed at age 6 years underwent investigation of involuntary movements. She developed continuous left-sided hemichoreoathetosis at age 11 after addition of valproic acid (VPA)… Click to show full abstract
A 24-year-old woman with Rasmussen encephalitis diagnosed at age 6 years underwent investigation of involuntary movements. She developed continuous left-sided hemichoreoathetosis at age 11 after addition of valproic acid (VPA) to carbamazepine and phenobarbital therapy. Admission workup was unremarkable, except for toxic VPA levels (129 mg/L). Cessation of movements was observed the day after VPA was discontinued (Video 1).
               
Click one of the above tabs to view related content.